These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9123796)

  • 1. Pharmacokinetic and pharmacodynamic studies on phenylbutazone and oxyphenbutazone in goats.
    Cheng Z; Welsh E; Nolan A; McKellar QA
    Vet Rec; 1997 Jan; 140(2):40-3. PubMed ID: 9123796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylbutazone pharmacokinetics and bioavailability in the dromedary camel (Camelus dromedarius).
    Kadir A; Ali BH; al Hadrami G; Bashir AK; Landoni MF; Lees P
    J Vet Pharmacol Ther; 1997 Feb; 20(1):54-60. PubMed ID: 9049950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in clinically normal horses and donkeys.
    Mealey KL; Matthews NS; Peck KE; Ray AC; Taylor TS
    Am J Vet Res; 1997 Jan; 58(1):53-5. PubMed ID: 8989496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of phenylbutazone and oxyphenbutazone in the donkey.
    Cheng Z; McKellar QA; Nolan A; Lees P
    J Vet Pharmacol Ther; 1996 Apr; 19(2):149-51. PubMed ID: 8735424
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
    Matthews NS; Peck KE; Taylor TS; Mealey KL
    Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The concentration changes of different phenylbutazone formulations in horse plasma].
    Keller H; Hashem A
    Dtsch Tierarztl Wochenschr; 1996 Jun; 103(6):224-30. PubMed ID: 8766906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of inflammation on the disposition of phenylbutazone in thoroughbred horses.
    Mills PC; Ng JC; Auer DE
    J Vet Pharmacol Ther; 1996 Dec; 19(6):475-81. PubMed ID: 8971677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of intravenous and intragastric cimetidine in horses. I. Effects of intravenous cimetidine on pharmacokinetics of intravenous phenylbutazone.
    Sams RA; Gerken DF; Dyke TM; Reed SM; Ashcraft SM
    J Vet Pharmacol Ther; 1997 Oct; 20(5):355-61. PubMed ID: 9350255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylbutazone in racing greyhounds: plasma and urinary residues 24 and 48 hours after a single intravenous administration.
    Mills PC; Ng JC; Skelton KV; Seawright AA; Auer DE
    Aust Vet J; 1995 Aug; 72(8):304-8. PubMed ID: 8579562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics, metabolism and excretion of phenylbutazone in cattle following intravenous, intramuscular and oral administration.
    Lees P; Ayliffe T; Maitho TE; Taylor JB
    Res Vet Sci; 1988 Jan; 44(1):57-67. PubMed ID: 3375589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics and pharmacokinetics of phenylbutazone in calves.
    Arifah AK; Lees P
    J Vet Pharmacol Ther; 2002 Aug; 25(4):299-309. PubMed ID: 12213119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic studies of flunixin meglumine and phenylbutazone in plasma, exudate and transudate in sheep.
    Cheng Z; McKeller Q; Nolan A
    J Vet Pharmacol Ther; 1998 Aug; 21(4):315-21. PubMed ID: 9731955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of concurrent administration of phenylbutazone and flunixin meglumine on pharmacokinetic variables and in vitro generation of thromboxane B2 in mares.
    Semrad SD; Sams RA; Harris ON; Ashcraft SM
    Am J Vet Res; 1993 Nov; 54(11):1901-5. PubMed ID: 8291770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of phenylbutazone in llamas following single intravenous and oral doses.
    Navarre CB; Ravis WR; Nagilla R; Simpkins A; Duran SH; Pugh DG
    J Vet Pharmacol Ther; 2001 Jun; 24(3):227-31. PubMed ID: 11442803
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively (author's transl)].
    Spahn H; Mutschler E; Geissler HE; Faust-Tinnefeldt G
    Arzneimittelforschung; 1981; 31(3):499-503. PubMed ID: 6894380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absorption of phenylbutazone from a paste formulation administered orally to the horse.
    Lees P; Higgins AJ; Mawhinney IC; Reid DS
    Res Vet Sci; 1986 Sep; 41(2):200-6. PubMed ID: 3775111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma and serum concentrations of phenylbutazone and oxyphenbutazone in racing Thoroughbreds 24 hours after treatment with various dosage regimens.
    Soma LR; Sams R; Duer W; Tobin T; Woodward C; McDonald J
    Am J Vet Res; 1985 Apr; 46(4):932-8. PubMed ID: 4014842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.